A PBM audit that flags an expired prescription or a refill beyond authorization can turn one claim into a recoupment demand across the entire lookback period. The auditor compares the fill date against the prescription's validity window and the refill count against what the prescriber authorized, and a mismatch on either one produces an audit finding. A prescriber's after-the-fact assurance does not cure it. The rule that caps refills for a Schedule III or Schedule IV controlled substance is not the same rule that caps a general prescription under state law, and that distinction can decide whether the finding is defensible.
How Auditors Test Prescription Validity and Refill Counts
PBM audit teams pull the claim adjudication log for each flagged claim and line it up against two dates: the date the prescription was written and the date the claim was last authorized to be refilled. A claim that adjudicates after the prescription's validity window closes, or after the authorized refill count is exhausted, gets flagged as filled on an expired or over-refilled prescription. Once a pattern shows up in the sample, the PBM applies extrapolation to project the finding across the full lookback period, so a handful of mismatched dates on the sample claims can become a demand covering every claim billed during the audit window.
Expired-prescription and refill-count findings are not the only claim-level mismatches a PBM audit tests. A related finding covers claims filled too soon rather than too late, worked out in Refill-Too-Soon Audit Findings and How to Rebut Them, and another covers quantity discrepancies on split fills, covered in Partial Fills and Audit Discrepancies.
The Authorizations That Cure a Finding
A flagged claim survives when the pharmacy can produce a prescriber's authorization that predates the fill, not one obtained after the audit notice arrives. A new written or electronic prescription, a documented refill authorization recorded in the patient's chart before dispensing, or a renewal order the prescriber actually gave before the fill date can each cure the finding. A verbal assurance gathered after the PBM already flagged the claim does not cure it, because the authorization has to predate the dispensing, not follow the audit.
A refill authorization obtained after the audit notice arrives, rather than before the claim was filled, does not cure a validity or refill-count finding.
The Federal Refill Limit for Controlled Substances
Federal law sets a fixed ceiling for Schedule III and Schedule IV controlled substances. Under 21 CFR 1306.22, a prescription for a Schedule III or IV controlled substance cannot be filled or refilled more than six months after the date it was issued, and it cannot be refilled more than five times, regardless of how many refills the prescriber wrote on the prescription. The cap is numeric and fixed; the prescriber's intent does not extend it.
New Jersey's General Refill Rule, by Comparison
New Jersey's general refill rule works on a different structure for a prescription that is not a Schedule III or IV controlled substance. Under N.J.A.C. 13:39-7.3, a prescription for a drug sold only on prescription stays valid for one year from the date it was issued, and the refill count is whatever the prescriber wrote on the original prescription, not a fixed federal number. Once those refills are used, the pharmacy needs a new prescription. For a Schedule III or IV controlled substance, the federal cap at 21 CFR 1306.22 is the more restrictive limit regardless of New Jersey's one-year window, so a pharmacy defending a flagged general prescription in New Jersey is arguing against the one-year window and the prescriber's own refill count, not against a five-refill federal cap that applies only to scheduled drugs.
Health Law Alliance's attorneys have overseen 2,000+ audits and handled 5,000+ matters, with 25+ years of experience.
Why Early Legal Counsel Is Critical
Pharmacies should retain healthcare defense counsel as soon as a PBM audit notice flags expired prescriptions or refills beyond authorization. Early legal intervention can identify which refill rule, federal or state, actually governs the flagged claim, assemble the prescriber authorization that predates the fill, and preserve the right to an audit appeal, before a recoupment, or an interim payment hold, becomes final. Delaying counsel until after the response deadline narrows these options.
How Health Law Alliance Can Help
Health Law Alliance's PBM audit defense attorneys represent pharmacies nationwide in audits that turn on prescription validity dates and refill counts, including matters where the PBM applied the wrong refill rule to the claim. Contact us for a free, confidential consultation.
